High versus Low-Intensity Resistance Training on Bone Mineral Density and Content Acquisition by Postmenopausal Women with Osteopenia: A Randomized Controlled Trial
Medical Journal of The Islamic Republic of Iran · 20.10.2023
DOI: 10.47176/mjiri.37.126 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Journal of The Islamic Republic of Iran, online erschienen am 20.10.2023. Verfasst von Fatemeh Eslamipour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Sport Rehabilitation, Faculty of Sport Sciences and Health, Shahid Beheshti University, Tehran, Iran. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health and Sport Rehabilitation, Faculty of Sport Sciences and Health, Shahid Beheshti University, Tehran, Iran.
ORCID-Profile: Mehdi Gheitasi
Zitieren
APA
Eslamipour, F., Gheitasi, M., Hovanloo, F., & Yaghoubitajani, Z. (2023). High versus Low-Intensity Resistance Training on Bone Mineral Density and Content Acquisition by Postmenopausal Women with Osteopenia: A Randomized Controlled Trial. Medical Journal of The Islamic Republic of Iran. https://doi.org/10.47176/mjiri.37.126
Vancouver
Eslamipour F, Gheitasi M, Hovanloo F, Yaghoubitajani Z. High versus Low-Intensity Resistance Training on Bone Mineral Density and Content Acquisition by Postmenopausal Women with Osteopenia: A Randomized Controlled Trial. Medical Journal of The Islamic Republic of Iran. 2023. doi:10.47176/mjiri.37.126
BibTeX
@article{Eslamipour2023,
author = {Eslamipour, Fatemeh and Gheitasi, Mehdi and Hovanloo, Fariborz and Yaghoubitajani, Zohreh},
title = {High versus Low-Intensity Resistance Training on Bone Mineral Density and Content Acquisition by Postmenopausal Women with Osteopenia: A Randomized Controlled Trial},
journal = {Medical Journal of The Islamic Republic of Iran},
year = {2023},
doi = {10.47176/mjiri.37.126}
}
EUVIMED